Zortemib 3.5mg (Bortezomib Vials) 3.5mg

Zortemib 3.5mg is a prescription medication used for certain types of cancer treatment. This injectable form contains 3.5mg of bortezomib per vial, designed for clinical administration. It is manufactured by Zuvius Life Sciences and stored between 15-25°C. Always consult a healthcare professional before use.

Strength

3.5mg

Pack Size

Storage

15-25°

Manufacturer / TM Owner

Zuvius Life Sciences Pvt Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Zortemib 3.5mg is primarily used in the treatment of multiple myeloma and mantle cell lymphoma. It belongs to a class of drugs known as proteasome inhibitors, which help slow or stop the growth of cancer cells. Patients may wonder what is Zortemib 3.5mg used for, and it is important to note that it is prescribed under medical supervision for specific oncology indications.

Side Effects

Zortemib 3.5mg works by interfering with the growth of cancer cells, which can slow their spread in the body. Common effects may include temporary changes in blood cell counts or fatigue. Individual responses may vary, and side effects should be monitored by a healthcare provider.

Precautions & Warnings

Zortemib 3.5mg should be handled and administered by trained medical professionals in a clinical setting. It is important to store the medication within the recommended temperature range of 15-25°C. Patients should avoid exposure to extreme temperatures and keep the vial in its original packaging until use.

Avoid Interactions

Zortemib 3.5mg may interact with other medications, including certain antivirals, antifungals, and blood pressure drugs. Alcohol and grapefruit products may also affect its metabolism. Always inform your healthcare provider about all medications and supplements you are taking before starting treatment.

Frequently Asked Questions

Zortemib 3.5mg is used to treat certain types of cancer, including multiple myeloma and mantle cell lymphoma, as prescribed by a doctor.

Zortemib 3.5mg is given as an injection by a healthcare professional in a clinical setting.

Common effects may include changes in blood cell counts or fatigue, but these should be discussed with a healthcare provider.

Zortemib 3.5mg is a prescription medication and should only be obtained through licensed pharmacies with a valid prescription.

Store Zortemib 3.5mg between 15-25°C and protect it from light and moisture until ready for use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.